	Identification of STMN1 as a lactylationâ€‘related driver of lung cancer progression using Mendelian randomization. Mol Med Rep Cai Y, Zhong Y, Wang H, Zhu S, Huang F, Zhang Q, Hu S. PMID: 41930463 [PubMed - in process]
	Diagnostic importance of serum markers in lung cancer. Mol Med Rep Liang Q, Song J, Wei H, Ning L, He B, Zhang Z. PMID: 41930456 [PubMed - indexed for MEDLINE]
	Temporal trends in second primary malignancies among long-term survivors of multiple myeloma across treatment eras: a population-based analysis of the SEER database. Hematology Lu L, Lin S, Chen Y, Huang Y. PMID: 41930414 [PubMed - indexed for MEDLINE]
	The Nexus of Stemness, Telomere Stability, and Metabolic Reprogramming in Glioblastoma: Foundations of Tumor Persistence and Targets for Intervention. MedComm (2020) Sung JY, Hwang K. PMID: 41930350 [PubMed]
	Circulating Microbial Metabolites Predict Tumor Relapse and Chemotherapy Efficacy in Nasopharyngeal Carcinoma. MedComm (2020) Li JY, Yao Y, Tan XR, Si N, Jiang W, Lu YQ, Dai JH, Yu TT, Hu HC, Duan YF, Feng SY, Huang SW, Liang YL, Gong S, Liu N, Hu YM, Li YQ. PMID: 41930347 [PubMed]
	Results and Exploratory Biomarker Analyses of a Phase II Study CHANGEABLE: Combination of PD-1 Inhibitor and Niraparib in GErm-Line-mutAted Metastatic Breast Cancer. MedComm (2020) Zhang J, Du Y, Meng Y, Jin Y, Lin M, Shao X, Liu X, Mu Y, Liu Y, Hu Z. PMID: 41930344 [PubMed]
	Sulforaphane Synergizes With PD-1 Blockade Through Activating CD8(+) T Cells in Non-Small Cell Lung Cancer: Preclinical and Clinical Investigations. MedComm (2020) Li J, Liu J, Wang Z, Zhao M, You M, Fu Z, Guo C, Zhang T, Liu S, Yue D, Yang S, Li Y, Gao Q, Liu Y, Huang J, Wang L, Zhang Y. PMID: 41930330 [PubMed]
	Multiomics Research Strategies in Cancer: A Growing and Innovative Field. MedComm (2020) Du Z, Liu X, Lv Z, Wang B, Xia Y, Al-Duais WAM, Yan L, Zhang F, Li Y. PMID: 41930321 [PubMed]
	Predicting efficacy in patients with locally advanced/metastatic urothelial carcinoma (mUC) treated with immunotherapy using explainable machine learning approaches: the SamUR-AI trial on behalf of the Meet-URO group. ESMO Real World Data Digit Oncol Rametta A, Ferri S, Maruzzo M, Pierantoni F, Antonuzzo L, Rossi V, Buti S, Testi I, Zucali P, Mucciarini C, Stellato M, Provenzano L, Raggi D, Farè E, Pedrocchi ALG, Prelaj A, Necchi A, Procopio G, Miskovic V, Giannatempo P. PMID: 41930317 [PubMed]
	AI assistance in tumor multidisciplinary teams. ESMO Real World Data Digit Oncol Geukes Foppen RJ, Mork, Traverso A, Dienstmann R. PMID: 41930313 [PubMed]
	Real-world outcomes following PARP inhibitor maintenance in ovarian cancer by BRCA status: a retrospective cohort study. ESMO Real World Data Digit Oncol Zucker K, Pickwell-Smith B, Samani A, Sujenthiran A, Pittell H, Mpofu P, Hall G. PMID: 41930310 [PubMed]
	How artificial intelligence applied to digital pathology could guide treatment personalization in breast cancer. ESMO Real World Data Digit Oncol Ruelle T, Grinda T, Del Mastro L, Lacroix-Triki M, Pistilli B, Gessain G. PMID: 41930306 [PubMed]
	Automated extraction of temporalized tumor evolution from oncology EMRs using natural language processing. ESMO Real World Data Digit Oncol Vinot C, Ferté C, Gaboriaud T, Minvielle-Sebastia A, Dubois A, Schwob R, Mallah S, Pajiep M, Alliot JM, Ferreira A, Pons-Tostivint E, Mazieres J, Yazigi A. PMID: 41930305 [PubMed]
	Predictors of acute lymphopenia after radiotherapy for prostate cancer including pelvic node irradiation: results of a real-world prospective multi-centric study. ESMO Real World Data Digit Oncol Vavassori V, Pavarini M, Alborghetti L, Aimonetto S, Maggio A, Landoni V, Ferrari P, Bianculli A, Petrucci E, Cicchetti A, Farina B, Ubeira-Gabellini MG, Salmoiraghi P, Moretti E, Avuzzi B, Giandini T, Munoz F, Magli A, Noris Chiorda B, Sanguineti G, Waskiewicz JM, Rago L, Cante D, Girelli G, Villa E, Di Muzio NG, Rancati T, Fiorino C, Cozzarini C. PMID: 41930300 [PubMed]
	Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study. ESMO Real World Data Digit Oncol Cazzaniga ME, Cogliati V, Rossi E, Paris I, Borella F, Moretti G, Garrone O, Pistelli M, Palumbo R, Ferro A, Vici P, De Giorgi U, Madaro S, Coltelli L, Giordano M, Gambaro AR, Nicoletti SVL, Zustovich F, Landucci E, Gamucci T, Pepe FF, Galimberti S, Capici S. PMID: 41930299 [PubMed]
	Real-world demographics, clinical characteristics, and testing and treatment patterns in patients with non-small-cell lung cancer and extensive-stage small-cell lung cancer in Belgium: the AIBED study. ESMO Real World Data Digit Oncol Muylle KM, Decoster L, Verleyen D, Germonpre PR, Masuy I, Verheyden B, Oeste CL, Callewaert E, Derijcke S, Wauters E, Janssens A, Verbiest A. PMID: 41930294 [PubMed]
	Navigating the molecular landscape: integrated multiomics liquid biopsy for biomarker discovery in early detection and monitoring of colorectal cancer. Front Mol Biosci Fan X, Shi J, Shang Y, Xu H. PMID: 41930252 [PubMed]
	Multi-omics integration identifies PGAP3 as a tumor-intrinsic factor associated with CD8(+) T-cell exclusion in prostate cancer. Front Mol Biosci Liu W, Li G, Lei Y, Liu H, Wang B, Deng W, Hong Y, Long X. PMID: 41930249 [PubMed]
	Nano catalyzed green synthesis of chalcone derivatives and its anti-oxidant and anti-lung cancer potential validated through in vitro experimentals, in silico quantum chemical, molecular docking and simulation studies. In Silico Pharmacol Vadivel P, Thirumurugan C, Thirumalaisamy R, Lalitha A. PMID: 41930242 [PubMed]
	AI applications across the cancer pain care Continuum: applications and future directions. Front Pain Res (Lausanne) Zhu D, Zhenkai H. PMID: 41930234 [PubMed]

Articles 1 - 20 / 1923952

Page 1 of 96198



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy